• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食类黄酮对三种环 1 型人肠道微生物β-葡萄糖醛酸酶的抑制作用及构效关系。

Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases.

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao.

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao.

出版信息

Int J Biol Macromol. 2022 Nov 1;220:1532-1544. doi: 10.1016/j.ijbiomac.2022.09.018. Epub 2022 Sep 9.

DOI:10.1016/j.ijbiomac.2022.09.018
PMID:36096258
Abstract

Gut microbial β-glucuronidases (GUSs) inhibition is a new approach for managing some diseases and medication therapy. However, the structural and functional complexity of GUSs have posed tremendous challenges to discover specific or broad-spectrum GUSs inhibitors using Escherichia coli GUS (EcoGUS) alone. This study first assessed the effects of twenty-one dietary flavones employing three Loop 1-type GUSs of different taxonomic origins, which were considered to be the main GUSs involved in deglucuronidation of small molecules, on p-nitrophenyl-β-D-glucuronide hydrolysis and a structure-activity relationship is preliminarily proposed based on both in vitro assays and a docking study with representative compounds. EcoGUS and Staphylococcus pasteuri GUS showed largely similar inhibition propensities with potencies positively correlating with the total hydroxyl groups and those at ring B of flavones, while docking results revealed strong interactions developed via ring A and/or C. Streptococcus agalactiae GUS (SagaGUS) exhibited distinct inhibition propensities, displaying late-onset inhibition and steep dose-response profiles with most tested compounds. The α-helix in loop 1 region of SagaGUS which causes spatial hindrance but offers a hydrophobic surface for contacting with the carbonyl group on ring C of flavones is believed to be essential for the allosteric inhibition of SagaGUS. Taken together, the study with a series of flavones revealed varied preferences for GUSs belonging to the same Loop 1-type, highlighting the necessity of adopting multi-GUSs instead of EcoGUS alone for screening broad-spectrum GUSs inhibitors or tailoring the inhibition based on specific GUS structure.

摘要

肠道微生物β-葡糖苷酸酶(GUSs)抑制是管理某些疾病和药物治疗的新方法。然而,GUSs 的结构和功能复杂性使得仅使用大肠杆菌 GUS(EcoGUS)发现特异性或广谱 GUSs 抑制剂具有巨大挑战。本研究首次评估了二十一种饮食类黄酮对三种不同分类来源的 Loop 1 型 GUSs 的影响,这三种 GUSs 被认为是参与小分子去糖基化的主要 GUSs,基于体外测定和代表性化合物的对接研究,初步提出了一种结构-活性关系。EcoGUS 和粪肠球菌 GUS 表现出相似的抑制倾向,其效力与类黄酮的总羟基和 B 环上的羟基呈正相关,而对接结果显示出通过 A 环和/或 C 环形成的强相互作用。无乳链球菌 GUS(SagaGUS)表现出明显不同的抑制倾向,表现出迟发性抑制和陡峭的剂量反应曲线,大多数测试化合物均如此。SagaGUS 中 Loop 1 区域的α-螺旋导致空间障碍,但为类黄酮 C 环上的羰基提供了一个疏水表面,被认为对 SagaGUS 的别构抑制至关重要。总之,该系列类黄酮的研究揭示了属于同一 Loop 1 型的 GUSs 存在不同的偏好,这突出了采用多 GUSs 而不是单独使用 EcoGUS 进行广谱 GUSs 抑制剂筛选或根据特定 GUS 结构进行抑制调整的必要性。

相似文献

1
Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases.饮食类黄酮对三种环 1 型人肠道微生物β-葡萄糖醛酸酶的抑制作用及构效关系。
Int J Biol Macromol. 2022 Nov 1;220:1532-1544. doi: 10.1016/j.ijbiomac.2022.09.018. Epub 2022 Sep 9.
2
Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10.从藤黄微球菌 3I10 中分离出一种高选择性和高效的甘草次酸水解β-葡萄糖醛酸酶的特性和分子决定因素。
Appl Microbiol Biotechnol. 2018 Nov;102(21):9193-9205. doi: 10.1007/s00253-018-9285-x. Epub 2018 Aug 14.
3
β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut.机会致病菌的β-葡糖苷酸酶是导致肠道中异物诱导毒性的主要因素。
Sci Rep. 2018 Nov 6;8(1):16372. doi: 10.1038/s41598-018-34678-z.
4
Substituent Position of Iminocyclitols Determines the Potency and Selectivity for Gut Microbial Xenobiotic-Reactivating Enzymes.取代基位置的咪唑环己醇决定了对肠道微生物外源性化合物激活酶的效力和选择性。
J Med Chem. 2020 May 14;63(9):4617-4627. doi: 10.1021/acs.jmedchem.9b01918. Epub 2020 Mar 9.
5
Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.结构、功能与药物重激活人肠道微生物 β-葡萄糖醛酸酶的抑制作用。
Sci Rep. 2019 Jan 29;9(1):825. doi: 10.1038/s41598-018-36069-w.
6
Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.利用基于活性的蛋白质谱技术发现导致药物毒性的微生物酶。
ACS Chem Biol. 2020 Jan 17;15(1):217-225. doi: 10.1021/acschembio.9b00788. Epub 2019 Dec 12.
7
Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome.在人类肠道微生物组中发现并表征黄素单核苷酸结合β-葡萄糖醛酸酶。
J Mol Biol. 2019 Mar 1;431(5):970-980. doi: 10.1016/j.jmb.2019.01.013. Epub 2019 Jan 15.
8
Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.肠道微生物 β-葡糖苷酸酶作为激活雌激素的组成部分重新激活雌激素,构成了雌激素组。
J Biol Chem. 2019 Dec 6;294(49):18586-18599. doi: 10.1074/jbc.RA119.010950. Epub 2019 Oct 21.
9
Microbial β-glucuronidases drive human periodontal disease etiology.微生物β-葡糖苷酸酶驱动人类牙周病病因学。
Sci Adv. 2023 May 5;9(18):eadg3390. doi: 10.1126/sciadv.adg3390.
10
Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota.阿莫沙平显示对人肠道微生物β-葡萄糖醛酸酶活性的不完全抑制。
SLAS Discov. 2018 Jan;23(1):76-83. doi: 10.1177/2472555217725264. Epub 2017 Aug 15.

引用本文的文献

1
Emerging gut microbial glycoside hydrolase inhibitors.新兴的肠道微生物糖苷水解酶抑制剂
RSC Chem Biol. 2025 Jun 11. doi: 10.1039/d5cb00050e.
2
Three bioactive compounds from Huangqin decoction ameliorate Irinotecan-induced diarrhea via dual-targeting of Escherichia coli and bacterial β-glucuronidase.黄芩汤中的三种生物活性化合物通过靶向大肠杆菌和细菌β-葡萄糖醛酸酶双重作用改善伊立替康所致腹泻。
Cell Biol Toxicol. 2024 Oct 18;40(1):88. doi: 10.1007/s10565-024-09922-0.
3
polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating abundance.
多糖通过调节丰度来强化肠道黏液屏障,以减轻肠道炎症。
Acta Pharm Sin B. 2024 Sep;14(9):3901-3915. doi: 10.1016/j.apsb.2024.06.002. Epub 2024 Jun 8.
4
Design, synthesis, and biological evaluation of (thio)urea derivatives as potent -glucuronidase inhibitors.设计、合成及(硫)脲衍生物作为强效 -葡萄糖醛酸酶抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2387415. doi: 10.1080/14756366.2024.2387415. Epub 2024 Aug 14.
5
Construction of Histone-Protein Complex Structures by Peptide Growing.通过肽段生长构建组蛋白-蛋白质复合物结构。
Int J Mol Sci. 2023 Sep 7;24(18):13831. doi: 10.3390/ijms241813831.
6
Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism.肠道微生物β-葡萄糖醛酸酶:女性雌激素代谢中的重要调节因子。
Gut Microbes. 2023 Jan-Dec;15(1):2236749. doi: 10.1080/19490976.2023.2236749.
7
Understanding the tonifying and the detoxifying properties of Chinese medicines from their impacts on gut microbiota and host metabolism: a case study with four medicinal herbs in experimental colitis rat model.从对肠道微生物群和宿主代谢的影响理解中药的补益和解毒特性:以实验性结肠炎大鼠模型中的四种草药为例
Chin Med. 2022 Oct 4;17(1):118. doi: 10.1186/s13020-022-00673-w.